Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab and epacadostat in thymic carcinoma is now displayed, with details on the study design, eligibility, treatments, outcomes, collaborators, and location. It also includes study history, publications, and a study protocol document.
    Difference
    50%
    Check dated 2026-11-07T12:24:16.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T13:17:04.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T16:41:50.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T16:24:02.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1; the displayed page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T16:35:44.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error screen instead of the expected content, signaling blocked access to the study record with a basic header and a Home option.
    Difference
    0.5%
    Check dated 2026-09-26T17:19:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.